2) releasing evaluation in vivo and in vitro
体内外释放度评价
3) Release rate in vitro
体外释放度
1.
Preparation of Naoluokang Sustained Release Capsules and Their Release Rate in Vitro;
脑络康缓释胶囊的制备工艺和体外释放度的研究
2.
Preparation of vaginal tinidazole microcapsules and observation of its release rate in vitro;
阴道用替硝唑缓释微囊的制备及其体外释放度考察
3.
Aim To prepare puerarin enteric nanoparticles and investigate their release rate in vitro.
目的制备葛根素肠溶纳米粒,并对其体外释放度进行考察。
4) release in vitro
体外释放度
1.
Study of Pseudoephedrine Hydrochloride Sustained-release Preparations and Its Release in vitro;
盐酸伪麻黄碱缓释制剂的研制及其体外释放度测定
2.
Studies on the Preparation and release in vitro of budesonide pulsatile controlled-release tablet for colon-specific delivery;
布地奈德结肠靶向脉冲片的制备及体外释放度研究
3.
Preparation of Gensenosides Microbore Osmotic Pump Tablet and Investigation of Release in vitro
人参总皂苷渗透泵片制备及体外释放度考察
5) dissolution in vitro
体外释放度
1.
Method:The dissolution in vitro of VIN-SEDDS were determined.
方法:进行了体外释放度实验,考察释放度实验方法学、释放介质、转速和制剂因素对药物释放特性的影响。
6) in vitro release rate
体外释放度
1.
Study on preparation of vitamin C sustained-release tablets and determination of in vitro release rate;
维生素C微囊缓释片的制备及体外释放度实验
2.
Objective:To establish the method and the in vitro release rate of gexintong sustained tablets.
目的:确定葛心通缓释片的体外释放度的测定方法及其体外释放度。
3.
Objective:To study the effects of formulation factors on in vitro release rate of ondan- setron hydrochloride (OND)-loaded microspheres.
目的:考察处方工艺参数对微球体外释放度的影响。
补充资料:体外释放
分子式:
CAS号:
性质:即将固体药物制剂模拟体内情况在体外所进行的释放试验。体内情况极为复杂,通常只能在温度、搅拌、介质pH值等方面加以模拟。具体实验方法因制剂类型、用途和理化性质等而异。口服缓释或控释制剂一般试验条件为温度37℃,释放介质为人工胃液和人工肠液,有时也可用水。常用的容器有转篮式、桨式、循环式及崩解仪式等数种。在规定时间取样,并及时补充所消耗的溶媒。
CAS号:
性质:即将固体药物制剂模拟体内情况在体外所进行的释放试验。体内情况极为复杂,通常只能在温度、搅拌、介质pH值等方面加以模拟。具体实验方法因制剂类型、用途和理化性质等而异。口服缓释或控释制剂一般试验条件为温度37℃,释放介质为人工胃液和人工肠液,有时也可用水。常用的容器有转篮式、桨式、循环式及崩解仪式等数种。在规定时间取样,并及时补充所消耗的溶媒。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条